Adam C. Naj,Farid Rajabli,Christiane Reitz,Gyungah Jun,Penelope Benchek,Giuseppe Tosto,Sha Jiang,Congcong Zhu,Nicholas A. Kushch,Wan‐Ping Lee,Jacob Haut,Kara L. Hamilton‐Nelson,Nicholas R. Wheeler,Yi Zhao,John Farrell,Michelle Grunin,Yuk Yee Leung,Donghe Li,Eder Lúcio da Fonseca,Jesse Mez,Ellen L. Palmer,Jagan A. Pillai,Richard Sherva,Yeunjoo E. Song,Xiaoling Zhang,Taha Iqbal,Omkar Pathak,Otto Valladares,Amanda B. Kuzma,Brian W. Kunkle,William S. Bush,Li‐San Wang,Lindsay A. Farrer,Jonathan L. Haines,Richard Mayeux,M.A. Pericak‐Vance,Gerald D. Schellenberg

Abstract:Background Lack of diversity in expanding genomic studies has limited the identification of LOAD risk variants that may be more prevalent in non‐European ancestry groups with more modest power requirements for detection. To help reverse this trend, we constructed and analyzed a multi‐ancestry collection of GWAS datasets in the Alzheimer’s Disease Genetics Consortium (ADGC) to identify novel shared and ancestry‐unique LOAD susceptibility loci and related biological pathways. Method The multi‐ancestry data collection of the ADGC includes GWAS genotype and phenotype data on 38,774 non‐Hispanic White (NHW), 7,454 African American (AA), 11,436 Hispanic (HI), and 3,277 East Asian (EAS) subjects imputed to the NHLBI TOPMed v5 reference panel. We performed a two‐stage analysis: (1) single‐variant association using score‐based logistic regression for population‐based datasets and generalized linear mix‐models for family studies with covariate adjustment for onset/exam age, sex, principal components for population substructure, and APOE ε2/ε3/ε4 genotype, followed by within‐ancestry fixed‐effects meta‐analysis using METAL; and (2) cross‐ancestry meta‐analysis of within‐ancestry associations using random‐effects modeling (RE2) in METASOFT. Secondary analyses include pathway analysis using EnrichR and gene‐based association testing using SKAT‐O (on‐going). Result In addition to APOE region associations, we identified 13 loci with genome‐wide significant (GWS; P≤5×10 −8 ) cross‐ancestry associations including chromosomes 1q32.2 (CR1), 2q14 (BIN1), 6p21.1 (TREM2), 6p12.3 (CD2AP), 8p21.2 (PTK2B), 8p21.1 (CLU), 8q24.3 (SHARPIN), 11q12 (MS4A6A), 11q14 (PICALM), 19p13.3 (ABCA7), and novel loci at 11p2 (LRRC4C) and 12q24.13 (LHX5‐AS1). An additional 13 loci reached suggestive significance (P<10 −5 ), including loci with ancestry‐specific associations attaining GWS such as PALM2AKAP2 (P = 2.5×10 −8 in EAS), GRB14 (P = 1.7×10 −8 in HI), and KIAA0825 (P = 2.9×10 −8 in NHW). Follow‐up pathway analysis implicated multiple amyloid regulation pathways (strongest: negative regulation of APP catabolism, adjusted P = 1.6×10 −4 ) and the classical complement pathway (adjusted P = 1.3×10 −3 ). Follow‐up analyses including fine‐mapping and gene‐based analyses are on‐going. Conclusion Cross‐ancestry GWAS meta‐analyses identified novel LOAD susceptibility loci in/near LRRC4C and LHX5‐AS1, both with known roles in neuronal development, as well as several novel ancestry‐unique loci, showing their tremendous value for gene discovery with smaller sample sizes than current European ancestry LOAD GWAS. Even larger multi‐ancestry studies will provide even more power for further elucidating the genomics of LOAD.

Sex- and APOE-specific genetic risk factors for late-onset Alzheimer's disease: Evidence from gene-gene interaction of longevity-related loci

Gene- gene interaction between PPARG and APOE gene on late-onset Alzheimer’s disease: A case- control study in Chinese han population

Impact of sex and APOE-ε4 genotype on patterns of regional brain atrophy in Alzheimer's disease and healthy aging

Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease

Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE

Associations Between APOE Genotype and Cerebral Small-Vessel Disease: a Longitudinal Study

APOE ɛ4 allele and TOMM40‐APOC1 variants jointly contribute to survival to older ages

Genetic Burden for Late-Life Neurodegenerative Disease and Its Association With Early-Life Lipids, Brain, Behavior, and Cognition

Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer's disease

The combined risk effect among BIN1, CLU, and APOE genes in Alzheimer's disease

The Interaction Effects of Age, APOE and Common Environmental Risk Factors on Human Brain Structure

Polygenic Analysis of Late-Onset Alzheimer'S Disease from Mainland China

APOE, TOMM40, and sex interactions on neural network connectivity

Genetically regulated expression in late-onset Alzheimer’s disease implicates risk genes within known and novel loci

Integrated genomic analysis revealed associated genes for Alzheimer's disease in APOE4 non-carriers.

Multi‐Ancestry Genome‐wide Association Analysis of Late‐Onset Alzheimer’s Disease (LOAD) in 60,941 Individuals Identifies Multiple Novel Cross‐Ancestry Associations and Implicates Amyloid and Complement Pathways

In vivo validation of late‐onset Alzheimer's disease genetic risk factors

APOE epsilon variants and composite risk of dementia, disability, and death in the health and retirement study

Association and Gene-Gene Interactions Study of Late-Onset Alzheimer's Disease in the Russian Population

Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture

Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants.